drugset / Trial / NCT00206622
Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the lowest effective dose of estradiol by comparing E2/LNG (2.2mg/0.69mg) and E2 (1.0mg) dose with placebo in decreasing the frequency and severity of moderate to severe hot flushes in postmenopausal women
Timeline
- Start
- 2004-12
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 1 mg | Other |
| Comparator | Estradiol | Other / unclassified | 2.2 mg | Other |
| Comparator | Levonorgestrel | Small molecule | 0.69 mg | Other |
Indications
No indication recorded.